Targeting regulatory T cells could boost the effects of cancer immunotherapy

[News]

A Ludwig Cancer Research study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the harsh microenvironment of the tumor.

More... (https://www.news-medical.net/news/20200217/Targeting-regulatory-T-cells-could-boost-the-effects-of-cancer-immunotherapy.aspx)